Advertising compliance screening for agencies with clinic clients.
Health advertising in Australia is governed by rules that sit across several documents, get updated without much fanfare, and rarely make it into a copy brief. Scriptline reads your clients' public pages against the current TGA and Ahpra guidance and tells you which sentences a reviewer would stop on. Every finding comes with the sentence itself, the rule behind it, and a link to the source, so you can check my work rather than trust it.
Run by one person in Sydney. Replies come from me, usually same day.
- Covers
- TGA & Ahpra advertising guidance
- Reads
- Public web pages and public archives
- Grades
- Five confidence tiers, A to E
- Returns
- A PDF you can forward to a client
- Based
- Sydney, New South Wales
Page text — invented sample
Sample Health Co. is a doctor-led telehealth service supporting patients across Australia.
Our practitioners prescribe medicinal cannabis for eligible patients living with chronic pain, anxiety and sleep conditions. Studies show it reduces pain and helps patients lower their opioid dose.
Complete our two-minute eligibility check and receive an e-script delivered to your door within 24 hours. No referral needed.
We also offer wrinkle-reducing injections from $9 per unit. Results guaranteed, or your next treatment is free.
Sample Health Co. does not advocate the use of therapeutic goods that have not been assessed by the TGA. Information on this page is for educational purposes only.
Findings 0
The page above is invented for this demonstration. It is not any real clinic's copy, and "Sample Health Co." is not a real business. Tier letters and rule codes such as A5 or T1 are Scriptline's own internal references. The citation is the linked source, never the code.
Names a prescription-only medicine, or makes a therapeutic claim about one.
Restricted representation, or supply framing around a prescription pathway.
Pricing, inducement and cosmetic-procedure presentation issues.
Low-confidence wording worth knowing about. Listed, never escalated.
Matched a rule, then ruled out on review. Reported with the reason.
Issued by the TGA in one enforcement action in 2023 against six businesses and two individuals over medicinal cannabis advertising. It is one batch, not the running total. TGA media release
The National Boards' guidelines for advertising higher risk non-surgical cosmetic procedures commenced, administered by Ahpra. Read the guidelines
Roughly how long it takes to check any single finding I send you, because the quote and the source link are both on the line.
What the screen looks for
Three categories that a find-and-replace misses.
Obvious breaches are easy and rare. What actually turns up in a portfolio is a substitute word chosen because it isn't the banned one, a therapeutic claim sitting inside a patient testimonial, and a line written years ago that nobody has re-read since.
References to prescription-only medicines
Trade names and active substances, plus the indirect categories the TGA has said may draw a consumer's mind to a Schedule 4 or Schedule 8 good.
- Substitute terms and euphemisms
- Abbreviations, hashtags, deliberate misspellings
- Page titles and meta descriptions as well as body copy
Restricted representations and prohibited language
Read against the National Boards' guidelines for advertising higher risk non-surgical cosmetic procedures, alongside published TGA advertising guidance.
- Safety claims and guaranteed outcomes
- Testimonials and before-and-after imagery
- Inducements, price framing, youth-targeting signals
When the wording first appeared
Public archive snapshots show roughly when a line went up and whether it has been there since. Useful mostly for triage: a paragraph written in 2022 usually predates the guidance it now sits awkwardly against, and that changes how you'd fix it.
- Read from public archives, not from anyone's server
- Reported only where snapshots actually exist
- Left out entirely rather than estimated
The report
Most of the work is deciding what to leave out.
Generating a long list of alarming matches is easy, and useless. The number that matters is how many of them still stand after someone reads the page they came from.
Cleared matches are in the report too
Where a site carries a compliant disclaimer, or correctly explains that it can't name a product, the match is listed as suppressed with the reason. My false-positive rate is as visible to you as my findings are.
A source link on every line
Each rule carries a confidence tier and a link to the TGA or Ahpra material behind it. If something doesn't hold up, you'll see that in under a minute, and I'd want to know about it. That's how the rule set gets better.
Written for whoever has to fix it
Findings are grouped by site and by the edit that resolves them, so a copywriter can work from the report directly. No legal glossary required.
Prescription-only medicine named outright
2 sites · Tier A · quoted, with source link
Substitute term standing in for a substance
2 sites · Tier A/B · a pattern the TGA has described
Minor wording, no action recommended
23 sites · Tier D/E · listed, not escalated
Matched, then cleared on review
Compliant disclaimers · reported as suppressed, with reasons
Unreachable when screened
Reported as unreachable. An unreachable site isn't a clear one.
Who I work with
The report goes to my client and nowhere else.
Scriptline sends findings to the organisation that engaged it, and to no one else. I don't contact clinics, patients, competitors or regulators, and I don't report anyone to anyone — whether or not they're a paying client. If that ever changed I'd say so here first.
Marketing and web agencies
With health, clinic, cosmetic or telehealth clients, where copy decisions are made in your studio and reviewed on your timeline.
Insurers and brokers
Professional indemnity in the medical and cosmetic space, where advertising conduct comes up at underwriting.
Networks and industry bodies
Franchise groups, practice networks and associations screening a member base rather than one site.
Pricing
Two numbers, both on the page.
Start with the audit. The monthly only makes sense afterwards, once you've seen whether the findings were any good.
Portfolio audit
$1,200 one-off · portfolios up to 40 sitesA full screen of the client sites you manage, written up as a report you can forward to a client without editing it first. Larger books quoted before I start.
- Every finding quoted, tiered and linked
- Suppressed matches listed with reasons
- Archive history where snapshots exist
- PDF, usually within a week
Ongoing screening
$600 per month · same portfolioThe same screen re-run monthly against a change log, so new copy gets looked at close to when it goes live.
- Monthly re-screen, changes flagged
- New pages picked up as they appear
- Rule set updated as guidance moves
- Month to month, cancel any time
Scriptline is a sole trader and isn't registered for GST, so these figures are the totals you'd pay. Invoices are issued as "Invoice" with no GST line, which also means there's no input tax credit for your finance team to claim. Worth knowing before you put it through procurement.
Limits of this service
What screening can and can't tell you.
Findings indicate matters requiring review. They are not determinations of breach. Whether a contravention has occurred is decided by the Therapeutic Goods Administration, by a National Board through Ahpra, by a tribunal or court, or in some cases by a state complaints body. Not by me, and not by a script.
Automated screening is indicative only and every match needs human review in context. Scriptline does not provide legal advice and is not a law firm. Where a finding raises a question that needs one, get a lawyer.
Scriptline is an independent private business. It has no affiliation with, endorsement from, or authority on behalf of the TGA, Ahpra or any regulator.
Screening covers publicly accessible web pages and public archives. It obeys robots.txt, runs rate limited, and identifies itself with a contactable user agent in your server logs.
Tier letters and rule codes are Scriptline's own internal references, not citations to any published instrument. The citation is always the linked source.
Free single-site scan
Send me one domain.
Pick the client site you'd least like to be surprised by. I'll screen it and send back what I find, at no charge and with nothing attached. It's the quickest way to judge whether any of this is worth your money.
Prefer email? hello@scriptline.com.au